A
ANVS
Annovis Bio Inc
1.590
-0.030-1.85%Pre Market: 1.570 -0.020 -1.26%08:23 04/13 EDT
OPEN/PREV CLOSE1.640/1.620
TODAY RANGE1.541-1.640
VOL19.03K
MARKET CAP45.08M
52 WEEK RANGE1.110-5.50
AVG VOL (3M)601.81K
% TURNOVER9.29%
TURNOVER0
P/E (TTM)-1.1325
% RANGE5.86%
EPS(TTM)-1.4040
P/E(FORWARD)-1.2720
P/B2.566
BVPS0.6196
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP37.44M
SHARES OUTSTANDING28.36M
NEXT EARNINGS05/11-05/15
FREE FLOAT23.55M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·3d ago
Annovis Bio Prices Registered Direct Offering to Fund Trials
Benzinga·3d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
NASDAQ·3d ago
Annoivs Bio Launches $10M Underwritten Offering
NASDAQ·6d ago
Monday 4/6 Insider Buying Report: ANVS, VALE
Benzinga·04/06 12:05
12 Health Care Stocks Moving In Monday's Pre-Market Session
TipRanks·04/04 02:02
Top Insider Makes Bold Multi-Million Dollar Move Into Annovis Bio
TipRanks·04/02 11:54
Annovis Bio secures U.S. patent for buntanetap
TipRanks·03/19 11:56
Annovis Bio enters partnership with NeuroRPM
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.